LILIA MYRNA RASUL: Open Payments
NPI 1255846473 · TOMBALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 25 payments from 8 companies in 2025. Trend: 2023 $485 · 2024 $244 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $214 |
| Exact Sciences Corporation | 6 | $114 |
| PFIZER INC. | 3 | $80 |
| Lilly USA, LLC | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Insulet Corporation | 1 | $28 |
| Abbott Laboratories | 1 | $24 |
| Amgen Inc. | 1 | $18 |
Products named: Ozempic, Cologuard Collection Kit, PREVNAR 20, FARXIGA, MOUNJARO, Omnipod, Wegovy, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
